Insider Activity of Shanmugam Muthusamy
Biography of Shanmugam Muthusamy
No biography is available at this moment.
No biography is available at this moment.
| 2025-08-21 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 52,988 0.2424% | $90.44 | $4.79M | -10.76% | |
| 2025-08-20 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 47,012 0.2159% | $90.27 | $4.24M | -10.24% | |
| 2025-08-15 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 52,990 0.2435% | $87.15 | $4.62M | -6.82% | |
| 2025-08-14 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 47,010 0.2155% | $89.48 | $4.21M | -9.43% | |
| 2025-05-09 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 700 0.0038% | $76.83 | $53,781 | +20.77% | |
| 2024-07-18 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 2,743 0.0132% | $62.00 | $170,066 | -2.22% | |
| 2024-07-17 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 14,257 0.0682% | $63.16 | $900,472 | -4.75% | |
| 2024-07-16 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 22,000 0.103% | $64.27 | $1.41M | -6.6% | |
| 2024-07-15 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 11,000 0.0508% | $63.38 | $697,180 | -5.11% | |
| 2024-06-21 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 20,000 0.0866% | $58.90 | $1.18M | +2.49% | |
| 2024-06-20 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 11,447 0.0503% | $59.86 | $685,217 | +0.92% | |
| 2024-06-18 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 10,607 0.0474% | $60.76 | $644,481 | -1.44% | |
| 2024-06-17 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 7,946 0.0359% | $61.41 | $487,964 | -3.1% | |
| 2024-05-20 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 12,855 0.0614% | $61.81 | $794,568 | -2.58% | |
| 2024-05-17 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 5,836 0.0269% | $62.09 | $362,357 | -2.13% | |
| 2024-05-16 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 16,459 0.078% | $63.84 | $1.05M | -5.67% | |
| 2024-05-15 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 14,850 0.0719% | $65.86 | $978,021 | -7.05% | |
| 2024-04-19 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 16,809 0.0797% | $65.17 | $1.1M | -7.9% | |
| 2024-04-18 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 10,423 0.05% | $64.98 | $677,287 | -6.57% | |
| 2024-04-17 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 9,520 0.0451% | $65.40 | $622,608 | -7.82% |